CARL J HAUSER, M.D.
Radiology at Francis St, Boston, MA
License number
Massachusetts 229518
Category
Radiology
Type
Surgical Critical Care
Address
Address
110 Francis St SUITE 2G, Boston, MA 02215
Phone
(617) 632-9929
Personal information
See more information about CARL J HAUSER at radaris.comName
Address
Phone
400 Pond St, Jamaica Plain, MA 02130
Professional information
Professor Of Surgery At Harvard Medical School
Position:
Professor of Surgery at Harvard Medical School
Location:
Greater Boston Area
Industry:
Medical Practice
Work:
Harvard Medical School
-
Professor of Surgery
Education:
New York University School of Medicine 1973 - 1977
MD, Medicine / Surgery
MD, Medicine / Surgery
Dr. Carl J Hauser, Boston MA - MD (Doctor of Medicine)
Specialties:
Critical Care Surgery
Address:
BETH ISRAEL DEACONESS MED CTR
110 Francis St SUITE 3A, Boston 02215
(617) 632-8634 (Phone), (617) 632-7424 (Fax)
Beth Israel Deaconness Sgy
110 Francis St SUITE 3A, Boston 02215
(617) 632-9922 (Phone)
110 Francis St SUITE 3A, Boston 02215
(617) 632-8634 (Phone), (617) 632-7424 (Fax)
Beth Israel Deaconness Sgy
110 Francis St SUITE 3A, Boston 02215
(617) 632-9922 (Phone)
Certifications:
Critical Care Surgery, 1993, General Surgery, 2003
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
New York University
Graduated: 1977
Harbor/UCLA Med Center
New York University
Graduated: 1977
Harbor/UCLA Med Center
Carl J Hauser, Boston MA
Specialties:
Surgeon
Address:
110 Francis St, Boston, MA 02215
Education:
New York University, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Surgery Certification in Surgery, American Board of Surgery Sub-certificate in Surgical Critical Care (Surgery)
Methods For Predicting And Treating Infection-Induced Illnesses And Predicting The Severity Of Infection-Induced Illnesses
US Patent:
2013024, Sep 19, 2013
Filed:
Dec 5, 2011
Appl. No.:
13/990605
Inventors:
Carl J. Hauser - Boston MA, US
Assignee:
Beth Israel Deaconess Medical Center, Inc. - Boston MA
International Classification:
C12Q 1/68, A61K 31/4706, A61K 38/48, A61K 38/17, A61K 39/395, A61K 45/06
US Classification:
4241721, 435 612, 424 9464, 514 205, 514313
Abstract:
The invention provides methods for determining the propensity to develop, or the presence of, one or more infection-induced illness(es). The invention further provides methods of treating an infection (e.g., bacterial infection), methods of diagnosing an infection-induced illness in a subject, and methods of predicting the future severity of one or more infection-induced illness(es). Also provided are kits for determining the likelihood or propensity of a subject to develop one or more infection-induced illness(es) and kits for diagnosing one or more infection-induced illness(es) in a subject and identifying a subject as having an increased risk of later developing one or more severe infection-induced illness(es).
Method For Predicting And Treating A Sterile Inflammation And Discriminating Between Sterile And Infective Inflammation
US Patent:
2012026, Oct 18, 2012
Filed:
Dec 3, 2010
Appl. No.:
13/513137
Inventors:
Carl J. Hauser - Boston MA, US
Assignee:
Beth Israel Deaconess Medical Center, Inc. - Boston MA
International Classification:
C12Q 1/68, A61K 31/4706, A61P 31/00, A61K 31/7088, A61P 29/00, A61K 38/13, A61K 39/395
US Classification:
4241721, 435 615, 514 205, 514313, 514 44 R, 435 612
Abstract:
The invention provides methods for predicting the likelihood that a subject will develop a sterile inflammation or will have an increased propensity to later develop a sterile inflammation, for determining whether a subject with tissue damage should be administered an antimicrobial agent (at full or a reduced dosage) or an anti-inflammatory agent, and for treating a subject with tissue damage. In the methods, an increased ratio of the amount of mitochondrial nucleic acid or peptide to the amount of microbial nucleic acid or peptide indicates a subject that has an increased likelihood of developing a sterile inflammation or an increased propensity to later develop a sterile inflammation, or a subject that should not be administered, or that should be administered at a reduced dosage, an antimicrobial agent or one or more anti-inflammatory agents and not an antimicrobial agent. Kits for detecting mitochondrial and/or microbial nucleic acids or peptides are provided.
Method For Modulating Inflammatory Responses By Altering Plasma Lipid Levels
US Patent:
2008003, Feb 7, 2008
Filed:
Jan 26, 2007
Appl. No.:
11/627891
Inventors:
Carl Hauser - Boston MA, US
Assignee:
UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY - New Brunswick NJ
International Classification:
A61K 38/38, A61K 31/397, A61K 31/56, A61P 37/00, A61K 31/724
US Classification:
514012000, 514182000, 514210020, 514058000
Abstract:
A method for treating an immune-related disorder in a patient comprising administering an agent to the patient for altering the patient's plasma concentration of free cholesterol, wherein said agent is a non-statin agent and is administered in an amount sufficient to modulate the immune-related disorder.